Neurological complication during imipenem/cilastatin therapy in uraemic patients.
Campise
M
M
D000368:Aged; D000369:Aged, 80 and over; D015377:Cilastatin / Q000008:administration & dosage / Q000009:adverse effects*; D003221:Confusion / Q000139:chemically induced; D005260:Female; D006801:Humans; D015378:Imipenem / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009420:Nervous System / Q000187:drug effects*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D010538:Peritonitis / Q000188:drug therapy; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D012640:Seizures / Q000139:chemically induced; D013845:Thienamycins / Q000008:administration & dosage / Q000009:adverse effects; D014202:Tremor / Q000139:chemically induced; D014511:Uremia / Q000628:therapy
D011480:Protease Inhibitors; D013845:Thienamycins; D015377:Cilastatin; D015378:Imipenem